4192.0 Cancer Epidemiology

Tuesday, November 10, 2009: 12:30 PM
This informative session will highlight a variety of issues in cancer epidemiology. Presentations will include discussion of a geospatial analysis of breast cancer, mammography, the estimated effect of estrogen exposures on mortality, the use of consumer expenditure profiles for cancer research and use of different prostate specific antigen cutoff points.
Session Objectives: 1. Describe a geospatial analysis of breast cancer incidence in Virginia. 2. Compare associations between breast cancer risk factors and mammographic density across 4 ethnic groups. 3. Evaluate the effect/s of hormonal exposures and estrogen receptor status at diagnosis on all-cause and breast cancer-specific mortality.

12:35 PM
Geospatial analysis of breast cancer incidence in Virginia 2000-2005: A methodological, analytical and policy perspective
Rexford Anson-Dwamena, MPH, Kenneth Studer, PhD, Michael Royster, MD, MPH, Kathy H. Wibberly, PhD and James Martin, PhD
12:50 PM
Hormone exposure and estrogen receptor status at breast cancer diagnosis: Implications on survival
Leona Bessonova, MS, CPH, Joan Largent, PhD, Argyrios Ziogas, PhD and Hoda Anton-Culver, PhD
1:05 PM
Mammographic Density in African American, Caribbean and Caucasian Women
Parisa Tehranifar, DrPH, Julie Flom, MPH and Mary Beth Terry, PhD
1:20 PM
Validating Area-Level Behavioral Profiles for Cancer Research
Ann Carroll Klassen, PhD, Frank C. Curriero, PhD and Stephanie Hsieh, ScM
1:35 PM
Case-control study of predictive level of prostate specific antigen (PSA) cutoff point
G. Reza Najem, MD, MPH, PhD, Patricia E. Gilhooly, MD and Birju Shah, MPH Student

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Epidemiology
Endorsed by: Statistics, Women's Caucus

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)

See more of: Epidemiology